You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1926 to 1950 of about 5897
Next 25
02/26/2015
Quicker Access to Experimental Drugs
NW BIO`S PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER APPROVED TO PROCEED IN CANADA AND UNDER WAY AT TWO SITES
The professor who `cured` his cancer with a cocktail of everyday pills and 20 years on remains disease-free
Cancer drug first tested in pet dogs begins human trials
Cancer Immunotherapy presentation
02/25/2015
UCLA 15th Annual Brain Tumor Conference
02/23/2015
Celldex`s Rindopepimut (Rintega(R)) Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma
02/21/2015
Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.
End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma
02/13/2015
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
02/10/2015
Could There Be a Gleevec for Brain Cancer?
"Historic Moment"
02/09/2015
Dr. Howard Fine Named Founding Director of the Brain Tumor Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center
02/04/2015
High hopes
02/02/2015
Dr. Howard Fine moved to Cornell!
01/31/2015
One Dose, Then Surgery: A New Way to Test Brain Tumor Drugs
Helmet-like device treats recurrent brain cancer
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.
01/24/2015
Could brain tumour survivors help unlock cancer cure?
01/22/2015
IBTA e-news
Birth Control Pill Risks May Now Include Brain Cancer
01/20/2015
CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)
01/15/2015
FDA reports one death, many ill after receiving intravenous fluids meant for training purposes
12/29/2014
FDA approves Opdivo for advanced melanoma
12/26/2014
The IBTA Newsletter